Main navigation
- Home
- About us
- Medicines
- Research
- Careers
- Responsibility
- Strategy and vision
- Patient safety
- Product counterfeiting
- Access to medicines
- In the developing world
- Sales & marketing
- Research ethics
- Clinical trials
- Our employees
- Community support
- Climate change
- Sustainable production
- Pharmaceuticals in the environment
- Working with suppliers
- Management & measurement
- Code, policies & standards
- Reporting performance
- Partnering
- Media
- Investors
You are here
- Home
- Responsibility
- Reporting performance
Annual reports

2008 Annual Report and 20-F Information 2008
Now available online as a dedicated website.
![]()
2007 Annual Report and Form 20-F Information
![]()
2007 Second Quarter and Half Year Report
2006 Annual reports and results of AGM 2007
![]()
2006 Second Quarter and Half Year Report and Chairman's Letter to UK Shareholders
2005 Annual reports and results of AGM 2006
![]()
2005 Second Quarter and Half Year Report
2004 Annual reports and results of AGM 2005
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share price